Fabiana Beatrice Simion

Dr. Fabiana Beatrice Simion


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MIMihai Iliescu-Glaja
Mihai Iliescu-Glaja
FSFabiana Beatrice Simion
Fabiana Beatrice Simion
Dana StoianDana Stoian
Dana Stoian
DGDaciana Grujic
Daciana Grujic
CTCristi Tarta
Cristi Tarta
AMAndrei Gheorghe Marius Motoc
Andrei Gheorghe Marius Motoc
Capsular contracture (CC) remains the most common long-term complication of implant-based breast reconstruction (IBBR), significantly impacting cosmetic outcomes, patient satisfaction, and reoperation rates. Despite substantial advances in surgical technique, implant technology, and perioperative management, the incidence of clinically significant contracture persists at approximately 3–5% at five years in non-irradiated patients and escalates dramatically—to 20–50%—in those receiving postmastectomy radiation therapy (PMRT). The etiology is multifactorial, involving subclinical biofilm formation, a dysregulated host immune and foreign-body response, and radiation-induced fibrosis. This narrative review synthesizes contemporary evidence on the pathophysiology, clinical assessment, and modifiable risk factors for CC in IBBR, with particular emphasis on implant surface characteristics (smooth, textured, and polyurethane[PU]-coated), placement plane (prepectoral versus subpectoral), the role of acellular dermal matrices (ADMs), reconstruction timing (direct-to-implant versus two-stage), and the complex interplay with radiotherapy—including radiation timing, fractionation, and emerging delivery techniques. We also address ongoing controversies, including the lack of standardized objective diagnostic criteria, the comparative effectiveness of ADM versus PU-coated implants, and the optimal sequencing of radiation relative to reconstruction. By integrating the latest evidence from very recent major meta-analyses and national registries, this review provides an updated synthesis. We further propose an evidence-based clinical decision framework for CC risk mitigation. This review aims to inform individualized surgical decision-making and identify priority areas for future investigation.

23 May 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MIMihai Iliescu-Glaja
Mihai Iliescu-Glaja
FSFabiana Beatrice Simion
Fabiana Beatrice Simion
Dana StoianDana Stoian
Dana Stoian
DGDaciana Grujic
Daciana Grujic
CTCristi Tarta
Cristi Tarta
AMAndrei Gheorghe Marius Motoc
Andrei Gheorghe Marius Motoc
Background/Objectives: Capsular contracture (CC) is the most frequent complication of breast implant surgery, affecting up to 20% of augmentation and up to 40% of post-mastectomy reconstruction patients. Diagnosis relies on the Baker classification with poor interobserver reliability (κ = 0.55). This study evaluated shear-wave elastography (SWE) as an objective diagnostic tool for CC via quantitative measurement of periprosthetic capsule stiffness. Methods: A prospective single-center comparative study (Romania) enrolled 26 augmentation patients (50 breasts) with asymptomatic Baker I/II CC as controls, and 25 breasts with confirmed Baker III/IV CC in post-mastectomy reconstruction patients as the study group. Stiffness was measured using the SuperSonic MACH 30 platform (mean, median, min, max, SD in kPa). Analysis included Mann-Whitney U tests, ROC curves with bootstrapped 95% CIs, and Youden’s J index. Confounder analyses (Spearman correlations, multivariable logistic regression, partial correlations) assessed the independence of SWE findings from implant depth, periprosthetic tissue thickness, region-of-interest (ROI) diameter, and body mass index (BMI). Results: All four primary stiffness parameters differed significantly between groups (p < 10−11, r > 0.97). Control median stiffness was 32.6 kPa versus 138.0 kPa in the study group. All four parameters achieved outstanding discriminative performance (AUC 0.988–0.994); SWE median yielded the highest AUC (0.994; 95% CI 0.980–1.000). A threshold of 82 kPa provided 100% sensitivity, 98% specificity, and 100% NPV. Baker Grades III (~92 kPa) and IV (~147 kPa) also differed significantly (p = 0.0001). No covariate (implant depth, periprosthetic tissue thickness, ROI diameter, BMI) significantly influenced SWE values within either group (all intra-group Spearman ρ p > 0.05), and SWE median stiffness remained the sole significant predictor in the fully adjusted multivariable model (adjusted OR = 1.18, 95% CI 1.08–1.31, p < 0.001). Conclusions: SWE objectively differentiates normal periprosthetic capsules from clinically significant CC with outstanding accuracy. An 82 kPa median stiffness threshold offers a reproducible, non-invasive complement to the Baker classification and provides a foundation for elastography-based CC staging.

4 January 2026 in Surgeries
Verified
Journal Article
Open access
PDF file
DGDaciana Grujic
Daciana Grujic
HCHoria Cristian
Horia Cristian
ADAlis Dema
Alis Dema
MIMihai Iliescu-Glaja
Mihai Iliescu-Glaja
THTeodora Hoinoiu
Teodora Hoinoiu
COCRISTINA OPREAN
CRISTINA OPREAN
Although occult breast carcinomas and lesions with uncertain malignant potential are rare, their incidental discovery during symmetrizing mammoplasty can significantly alter the treatment approaches and cancer staging. In the context of oncoplastic surgery, the systematic evaluation of the contralateral breast is a clinical priority that has been underexplored in Eastern Europe. Background/Objectives: This study aimed to assess the incidence and histological characteristics of incidental carcinomas and B 3 lesions detected during contralateral symmetry mammoplasty in patients with breast cancer. Methods: This retrospective study was conducted at the Plastic and Reconstructive Surgery Clinic of the “Pius Brînzeu” County Emergency Clinical Hospital in Timisoara, Romania, over six years (2018–2024), and included 180 of 256 patients who underwent contralateral breast symmetrization. Results: Among the 180 patients, 21 (11.66%) had incidental findings: eight (4.44%) had contralateral carcinomas, and 13 (7.22%) had B3 lesions. The histopathological types identified were invasive ductal carcinoma NST (one case), ductal carcinoma in situ (one case), invasive lobular carcinoma (five cases), and mucinous/papillary carcinoma (one case). Compared to the reported international range of 2–10%, our observed incidence of 11.66% reflects the unique aspects of our patient cohort and the thoroughness of our histological analyses. Conclusions: Detection of contralateral carcinomas and B3 lesions during symmetry mammoplasties underscores the importance of a multidisciplinary approach, comprehensive bilateral screening, and detailed histopathological examination of specimens.